Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioCryst announces $325m of funding from Royalty Pharma and Athyrium Capital Management
BioCryst announces $325m of funding from Royalty Pharma and Athyrium Capital Management. (Credit: Capri23auto from Pixabay)
BioCryst announces $325m of funding from Royalty Pharma and Athyrium Capital Management. (Credit: Capri23auto from Pixabay)